ASMBAssembly Biosciences, Inc.
$22.80-4.4% 1Y
$22.80
$22.1952 weeks$38.50
The financials
Assembly Biosciences, Inc. by the numbers
Assembly Biosciences, Inc. (ASMB) reported revenue of $13M in Q2 2026 (quarter ended Jun 30, 2026), up 39% from the same quarter a year earlier. That came with net loss of $3.9M. For the full year FY2025, revenue was $72M (+154% year on year) and net income −$6.1M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $13M | $9.6M | +39% |
| Operating income | −$6.3M | −$11M | n/a |
| Net income | −$3.9M | −$10M | n/a |
| Diluted EPS | −$0.20 | −$1.33 | n/a |